Académique Documents
Professionnel Documents
Culture Documents
Transferrin saturation, plasma iron turnover, and transferrin uptake in normal humans
M Cazzola, HA Huebers, MH Sayers, AP MacPhail, M Eng and CA Finch
Information about reproducing this article in parts or in its entirety may be found online at: http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#repub_requests Information about ordering reprints may be found online at: http://bloodjournal.hematologylibrary.org/site/misc/rights.xhtml#reprints Information about subscriptions and ASH membership may be found online at: http://bloodjournal.hematologylibrary.org/site/subscriptions/index.xhtml
Blood (print ISSN 0006-4971, online ISSN 1528-0020), is published weekly by the American Society of Hematology, 2021 L St, NW, Suite 900, Washington DC 20036. Copyright 2011 by The American Society of Hematology; all rights reserved.
Transferrin
Saturation,
Plasma
Iron
Turnover,
and Transferrin
By Mario Cazzola, Helmut
Mary
Uptake
A. Huebers,
Eng, and
in Normal
Merlin H. Sayers,
A. Finch
Humans
A. Patrick MacPhail,
Clement
The relationship between plasma iron. transferrin saturation, and plasma iron turnover was studied in 53 normal subjects whose transferrin saturation varied between 17% and 57%, in 25 normal subjects whose transferrin saturation was increased by iron infusion to between 67% and 1 00%. and in five subjects with early untreated idiopathic hemochromatosis whose transferrin saturation was continually elevated to between 61 % and 86%. The plasma iron turnover of all of these subjects ranged from 0.45 to
1
.22
mg/dL
whole
blood/d.
The
mean
values
for
the
above-mentioned three groups were 0.71 0.1 7. 1 .01 0.1 1. and 1 .01 0.13 mg/dL whole blood/d, respectively. Most of this variation, estimated at 72% by regression analysis. was due to a direct relationship between transferrin
attributed
saturation
and
plasma
iron
turnover.
This
effect
was
to a competitive advantage of diferric over monoferric transferrin in delivering iron to tissues. This was confirmed by the demonstration of a more rapid clearance of diferric as compared to monoferric transferrin in an additional group of eight normal subjects. Calcula-
tions were made of the amount of transferrin reacting with membrane receptors per unit time. Allowance was made for the noncellular (extravascular) exchange and for the 4.2:1 preference of diferric over monoferric transferrin demonstrated in vitro. The amount of iron-bearing transferrin leaving the plasma to bind to tissue receptors for 53 subjects with a transferrin saturation between 1 7% and 57% was 71 1 3; for 25 subjects with a saturation from 67% to 100%, 72 12; and for five subjects with early idiopathic hemochromatosis. 82 1 1 zmol/L whole blood/ d. There were no significant differences among these groups. These studies indicate that while the number of iron atoms delivered to the tissues increases with increasin9 plasma iron and transferrin saturation, the number of iron-bearing transferrin molecules that leave the plasma per unit time to bind to tissue receptors is relatively constant and within the limits studied. independent of
transferrin a 1985 saturation.
by Grune
& Stratton.
Inc.
F
acterize
studies have been used exchange, and more particularly, The assumption rests has been Recent studies
to
followed
maintain
by a continuous
the plasma iron
infusion
in an
amount
level.
calculated
Measurements during
to
of the
at a near-saturated
validity
behaves
of such
as a
calculations
single
pool.
plasma iron saturation were made at different times study. Five subjects who were incidentally found to have
transferrin ied. These saturation individuals after had repeated no symptoms determinations or splenomegaly were
an elevated
also studon physical
assumption is composed
ferric
to be invalid.79 The plasma of three different molecular one diferric transferrin. iron similarly in vivo, in their iron-donating
were determined
and
species diferric
in vivo netic basis
donate moiety
relationships
examination, had a normal Hct (43.6% I .3%), a normal reticulocyte count (1.1% 0.3%), a plasma ferritin concentration >500 zg/L, and a liver biopsy showing parenchymal iron deposition but no
hepatic fibrosis. These subjects were considered to represent individ-
studies
of previous
in normal
in vitro
and
used
4 Ci
for
an
studies,#{176} a formula
of plasma
of Fe
the the
number plasma
of per
to tissue
MATERIALS
and/or 2 zCi of pCi/ag of iron. the subject had were evaluated. label transferrin
neously. in vitro (pH
39Fe. Each isotope had a specific activity of about 10 Measurements were carried out in the morning after fasted. Initially, several different methods of tagging In these studies, two different isotopes were used to in different fashions and were injected simultatagging 2) to was 10 mL carried out by adding plasma a tracer with amount constant of heparinized
Experimental
subjects. protocols of
formed
Experimental University informed
good
on 53 normal
In vivo ferrokinetic studies were pervolunteers between the ages of 21 and 40.
for these Human from studies were Subjects all subjects. approved Committee All subjects were by the and in
of 55FeSO4
From
versity Submitted
the Department
of Washington. Nov 5, 1984;
of Medicine,
Seattle. accepted
Hematology
April 16, 1985.
Research.
Uni-
consent
health, had a hematocrit (Hct) 40 (males) or 35 (females), transferrin saturation between 20% and 60%. In a few instances, the transferrin saturation, when repeated at the time of the study, was found to be outside of this range. In addition, the plasma iron turnover was determined in 25 subjects after the plasma iron had been artificially raised by an infusion of ferrous ammonium sulfate. In I 6 of these subjects, plasma iron turnover had been first determined under basal conditions a few hours before. For the second turnover, a cold ferrous iron infusion was given over a period and
a
in part by National Institutes of Health Grant No. HL06242, a grant from the Italian Association for Cancer Research, and Grant No. 84.00505.44 from Progetto Finalizzato Oncologia. Computer assistance was provided by CLINFO Computer System, funded under General Clinical Research Grant No. RR-37 from the National Institutes of Health. A portion of the work was conducted in the Clinical Research Center under Grant
No. RR-37
Supported
of ten
minutes
immediately
following
the
injection
of a trace
amount
of a second isotope of iron. The amount of cold iron injected was designed to increase the in vivo saturation to about 90%, that calculation being based on the unsaturated iron-binding capacity and estimated plasma volume. In six subjects, the single dose was
1985: pp 935-939
Address reprint requests to Clement A. Finch, MD, Hematology Research. 4 East, Providence Hospital, ZD-20, 500 1 7th Ave. Seattle, WA 98124.
I 985
by Grune
& Stratton,
Inc.
0006-4971/85/6604-0029$03.00/0
Blood,
Vol 66,
No 4 (October).
935
936
CAZZOLA
ET AL
Table
1 . Comparisons
Between
Methods
of Labeling
bated
formula:
to 0 time,
and
from
the
Hct
according
to the
following
Transferrin
Between
(%)
0.92
-
Subjects 4 65FeS04.
Tagging in vivo
Blood
Predicted Volume
WBA
in which
extrapolated
WBA venous is whole Hct
0 time
blood
0.9 (Hct
0.92
at 0 time/lOO)
is the factor for
1.06
activity,
69FeSO4,
b
in vitro
in vitro in vitro used to
1 .00
0.98 0.98 label
0.15
and 0.98 is the factor accounting for trapped plasma (0.98 x 0.92 - 0.9). The adequacy of binding of radioiron to transferrin in vitro and in
converting to whole vivo
are
body
Hct,
Two
fashions
different
and were
isotopes inejcted
were
transferrin subject.
different
was from
the
calculated to the
blood blood
volume volume
of the calcu-
simultaneously
in each
Values
height2
expressed
as means
SD. Abbreviation:
WB,
whole
blood.
volume
agitation
so as to optimize
dispersion
iron
and
permit
random
plasma with
loading
and
of binding
sites.
was
Fe citrate
was similarly
tagged In vivo
added
tagging
to
compared
in vitro blood
(cpm/mL)
59FeSO4
intravenously
was carried out by injecting trace amounts of 59FeSO4 (pH 2) in a volume of 2 mL intravenously by pump over a period of five minutes. From these studies, it was concluded that trace labeling by any of the
methods used gave was their normal containing a Sephadex similar examined the simultaneous subjects. plasma column results by two in normal labeling plasma clearance was subjects5 (Table at low and 1). high and blood saturabuffer passed NJ).7
volume
(mL)
whole
body plasmatocrit
The
transferrin saturation, determining in eight tion,
effect
of altering
injecting
the proportion
of monoferric
plasma aliquots from exposed
and diferric
intravenously, the circulating plasma and of low this was to a phosphate Piscataway,
where the whole body plasmatocrit is equal to (1 00 Hct x 0.9)/ 100. Transferrin binding was considered adequate since calculations based on extrapolated activity differed by less than 10% from blood volumes calculated from height-weight ratios as described by
others.3 plished I). This was true regardless of whether tagging was injection accom(Table by in vitro incubation or by in vivo radioiron
In order
to provide
(pH
through
ofdesferrioxamine (Pharmacia,
The transferrin aliquot obtained had a plasma iron level of <20 ig/dL and to this, 59FeSO4 in tracer amounts was added and 15
minutes transferrin subjects was allowed for binding. The mean iron saturation of in the final abiquot was plasma was trace-labeled Carrier iron as ferrous 9% 4%. A second with FeSO4 and ammonium
transferrin saturation were measured using t9Fe activity was determined by gamma counting, while Fe activity was processed by the method of Eakins and Brown6 and then measured in a liquid scintillation counter.
standard Calculations of transferrin uptake. Additional calculations
Plasma
iron
and
aliquot
incubated was
of the
for then
is
minutes.
sulfate
were made to convert the plasma iron turnover to transferrin uptake. The plasma iron turnover at basal or elevated levels of plasma iron represented the actual turnover of iron in the plasma at the subjects
plasma iron-bearing ferrin, two iron level. transferrin additional In order calculations to determine by membrane were required. the rate receptors It was of uptake for transfirst necesof molecules
added in an amount calculated to saturate the binding capacity of the plasma. The final saturation was 96% 2%. The details of measurement of plasma iron turnover have been reported elsewhere.4 After intravenous injection of radioiron, five to six blood samples were drawn over the anticipated half-time
isotope plasma disappearance, iron determinations when the plasma iron usually were at least carried 120 out minutes. on the In initial addition, sample
and
at the estimated
of plasma
half-time
iron
during
was the
basal
artificially
turnovers
elevated.
and
In plasma
more
the iron
frequently calculations
sary to subtract that portion of plasma iron that was escaping into the extravascular space. Cook et al had previously derived a factor for extravascular flux (EVF). They identified the early reflux component of the plasma radioiron clearance curve as due to extravascular exchange. Application of regression analysis to this component showed it to be related to plasma iron concentration (r =
.71) and that it could be derived using the following formula:
turnover,
extrapolated
value (PIT)
at the t/4 was used. The calculation of plasma iron turnover was carried out employing the standard formula4: whole blood/d) PI(g/dL)
-
EVF
(mg/dL
wb/d)
-
PI(,g/dL)
x [(100 is presumed
receptors.
Hct to exit
x 0.9)/100] from
iron
x 0.0015.
x (100
Hct
x 0.9) The
blood clearance calculated
x 100
fraction
by binding
remaining
the circulating
uptake
-
to membrane
Tissue
(IU)
is
P1 is plasma
In some
iron concentration
instances, radioiron
is radioiron was
utilization
EVF. uptake
loading
to
on
from
the blood
activity
at 14 days,
the blood
activity
extrapo-
uptake.
demonstrated transferrin
transferrin
proportion
occurs
in vitro
the exact
51$
be determined
5Trace
may should be saturation
amounts
injected
plasma
subjects case,
in vitro
transferrin plasma then
or
of saturation
of transferrin
has membrane
It has
over Thus,
advantage transferrin
donor should
its saturation
be
it
possible
adjusted to that of the subject, using cold iron. Otherwise, there be incomplete binding of radioiron to transferrin and excessive from circulation.
may loss
molecules
receptors,
leave
the plasma
transferrin
to bind
to tissue
tissue iron
ie, tissue
uptake
transferrin
saturation.
In order
to express
iron
TRANSFERRIN
RECEPTOR
TURNOVER
937
in terms
of transferrin, of iron:
=
milligrams
of
iron
are
first
to micromoles whole
<
bbood/d) ratio
IU(mg/dL transferrin
to
52/100
x (10,000/56). turnover
saturation.
showed no significant differfor the predominantly monoferand turnover in Table between for the diferric form, in 53 group PIT and 85%
.
molecular
iron uptake S)/lOO from from
-
between
related
and
The
-
nc
87%
was 6% (P
>
90% .05).
8%
is then
transferrin
proportions
-
molecular
iron iron uptake uptake
diferric
-
being
and
TfFe,
4.2
the
transferrin,
diferric
it is possible
transferrin
to express
iron shown
this and
and
as follows:
was
a close
<
correlation
<
.81, P (r - .77,
and was
.001) P
saturation averaged
S)/l0O x total
+
iron uptake
5%
independent
plasma (r
= -
S)/lOO
8.452/100
.05)
and
transferrin
saturation
14, P>
iron
uptake
from
=
TfFe2
8.452/100
25(100 Considering that
-
iron uptake.
S)/lOO
average transferrin 1.01 0.11 mg/dL had a prior turnover basal conditions (Fig 12% and the PIT
saturation of 83% 1 1 %, their whole blood/d. Sixteen ofthese performed 1A). The 0.71
monoferric
transferrin
and diferric transferrin delivers two iron atoms at all times, the above-reported relationships permitted to derive the molecular ratio between transferrin and iron uptake: tissue transferrin
iron (iron (iron
was
uptake
uptake uptake uptake from from TfFe,) TfFe,)
+ +
/2(iron
tissue
During the second PIT, transferrin saturation had a mean value of 8 1% I 1 %, with a mean PIT of 1 .0 1 0. 1 1 mg/dL whole bbood/d. These values were significantly different (P aged basal did quent
<
uptake uptake
from from
TfFe2) TfFe2)
.001)
at
from
the
basal
elevated
values.
plasma
On
the
iron
other
hand,
red
cell
aver-
(iron
utilization
concentration
Thus,
transferrin
by substituting
with the
iron uptake
from
relationships,
monoferric
and diferric
not significantly different of 86% 5% (P > .05). normal equilibrium iron and concentration
from the mean The iron infusion there was a subse10 to averaging undergoing infusion
above-reported
it follows:
TU(zmol/L
whole
bbood/d) (200
-
fall in plasma
+ +
2.2S)
IU(zmol/L
whole
bbood/d) saturation.
x (200
6.45)
g/dL/h. tandem
where
S is the percentage
of transferrin RESULTS
maintain their elevated stable with an average and their plasma iron bbood/d. In the other decrease of 1 3 sg/dL was 1 .00 0. 1 1 mg/dL
An additional five
19 subjects who had an average plasma/h, the plasma iron turnover whole blood/d.
subjects with early idiopathic hemo-
disappearance transferrin
ferric
chromatosis
showed
a continued
elevation
of
transferrin
Table 2. Ferrokinetic
Ratio Plasma (ig/dL) Normalsubjectsstudied 112
Measurements
Between and Blood Radloiron t14 (mm) 97
Iron
Measured
Predicted
Volume
43
35
11
1.07
0.12
23
0.71
0.17
85 (n
-
under
(n
=
39)
Normal
(n
50
83
11
1 .07
0.09
1 62
33
1 .0 1
0. 1 1
84
7 19)
elevated
=
plasma
(n
iron 16)
109
(n
Normal
Under
conditions
43
34
12
1.07
0.10
92
24
0.71
0.15
86
5
-
At elevated levels
plasma
(n 51 31 81 72
10)
11
1.09
0.10
163
105
31
20
1.01
1.01
0.11
88 (n
-
6 10)
Precirrhoticidiopathichemochromatosis (n
=
12
1.02
0.11
0.13
80.89
5)
of radioiron
was studied
only in some
subjects
(numbers
within
parentheses).
938
CAZZOLA
ET AL
saturation
and
had
a mean
PITof
1.01
0.13
mg/dL
whole
a
1.4
A
a . a.. #{149} .#{149}:sa..:. . .: #{149}.. s
2O
208
bbood/d as shown in Table 2. Red cell utilization was normal (80% and 89%) in the two subjects studied
tissue
of radioiron who were in initial studied approaching iron turnover are of PIT
until
iron
the of
14th all
day,
lec 0
distribution.
The displayed
data
three had P
<
a#{176}#{149}
.
E
1
It is apparent
the regression
on transferrin
a curvilinear
I50
20
40
50
50
100
20
40
50
50
100
to transferrin uptake by membrane receptors receptor turnover) are displayed in Fig 1 B and no significant
ferrin
(transferrin 2B. There was the basal transand the after iron tandem
differ-
Transfirrln
saturatIon
(%)
difference
(P
>
.05)
between
value loading
uptake of 72
of 71 I I tmol/L group
(Fig
in the was
Fig 2. Relationship between transferrin saturation and (A) plasma iron turnover or (B) transferrin uptake in normal subjects studied on basal conditions (#{149}). normal subjects studied at elevated plasma iron and transferrin saturation (0). and subjects with precirrhotic idiopathic hemochromatosis (A).
ferrokinetic
studies
ence the 13
observed
of transferrin
uptake
between
erythroid
utilization
and
of
nonerythroid
radioiron by red
receptors,
cells
the
would
percentage
change with
of
a
53 normal subjects studied under zmol/L whole bbood/d) and the plasma iron levels (72
elevated
1 2 zmol/L
Subjects with early idiopathic hemochromatosis also showed values for transferrin uptake in the normal range. Figure 2B shows the independence of the transferrin receptor turnover on transferrin saturation (P
>
change in transferrin saturation, and this was not found. The explanation for this effect was disclosed by quantitative studies of transferrin iron loading and unloading.7#{176}89 While there have been earlier reports that the loading of transferrins nor
binding
sites binding
in concept
in vitro
rats, that
is neither
and binding
.05).
determined
sites,922
strengths
rabbits, the
of the
DISCUSSION
models through
kinetics and
those
have nonerythroid
tissue5.
been the
to simple
also of been transferrin
probability
shown that and
rules
tissue from
(random
distribumonoferric
designed
refluxes
into
consideration
of iron
various
and
diferric
forms
The
preferential
uptake
of
These measurements, while they may accurately reflect iron turnover, are determined not only by the number of tissue
receptors which take up the transferrin iron complex but also
receptors then explains the iron turnover which occurs in plasma iron and transferrin model flux and in
by the presented.
as
or more specifically, erythropoietic to remove the effect of plasma iron A relationship between plasma plasma et ab, turnover.7
1.4
capacity, it is necessary or transferrin saturation. iron concentration and sometime in the ago by Cook iron of behavior in nonerythroid
between a simple in vitro of all, there is an extravascular and its iron leave the
whereby
iron but
through the lymphatics. This et al28 and Cook et al,7 has been iron concentration.
to plasma
In the second
A
O
place, there is a continuous ing transferrin, which does Iron entering the vascular form a certain ferrin, thereby been previously
where rabbit,
release of tissue iron to circulatnot occur in the in vitro system. system would, therefore, transto diferric transkinetics. This has study
conversion
.
-
a
1.0
#{149}200
by us in a detailed
in the
has
S
-.
0
,.,
100
50
been obtained.7 Since mated those obtained with rabbit reticulocytes, formula based nc transferrin By such
mono/diferric
with rabbits approxiof rabbit transferrin appropriate to use a over monoferincubation.0 expressing of uptake the of
a.
I.-
20
40
60
so
100
20
40
80
80
100
of diferric reticubocyte
Tran sfsrrln
Fig i
.
saturatIon
transferrin
(%)
saturation and (A)
Relationship
between
plasma iron turnover or (B) transferrin studied on basal conditions and after basal value and the values at elevated saturation.
uptake. Each subject was iron loading. Lines join the plasma iron and transferrin
a curve has been defined from which the rate can be calculated. uptake transferrin in normal
The estimate of transferrin changes in plasma iron and by the similar values obtained
TRANSFERRIN
RECEPTOR
TURNOVER
939
conditions
and
with
artificially
elevated
plasma
iron.
Like-
opportunity concerns
the
trans-
wise,
normal
individuals state,
limits. Thus,
with
constant
while the
hyperferremia slightly
number
due were
atoms iron
to within
dcliv-
an
iron-loading
although
higher,
of
of ferroplasma
it is a simple
with increasing plasma iron and the number of iron-bearing transbinding to tissue receptors is relatively have certain practical
in a fashion
iron turnover provided radioiron is added properly, it is another matter to evaluate tissue capacity to assimilate iron. A near doubling of iron turnover (and erythroid marrow uptake since utilization merely by increasing does not imply that transferrin increased, receptors
tive poiesis,
constant. These
First of all,
observations
if radioiron
implications.
similar to
is to be cleared
the the
remains constant) can be obtained plasma iron concentration. This number of tissue receptors for or that erythropoiesis taken major
plasma
that of cold iron in patients, patient is to be measured, and diferric transferrin circulating patients plasma.
ie, if the true iron turnover of the the amount of labeled monoferric be made The identical to that in which in the this is been in an
a
has
been
altered
has
been up by objec-
must
manner
of ferrokinetic
erythrotrans-
ferrin
ity
effect
on turnover iron-the
from latter
the
intrinsic
marrow
capacity capac-
to assimilate
of the
reflecting
the functional
to remove
unbound
iron2
seems
unnecessary
and
REFERENCES
marrow.
CA, A, Gibbett I,
Deubelbeiss ER:
K, Cook
JD,
Eschbach J Clin
JW,
Harker
unsaturated
1978 16. Eakins
iron binding
JD, Brown Radiat
capacity
DA: An Isot G, model
in serum.
improved
Br J Haematol
method
38:281,
DD, Marsaglia
G, Hillman
Ferrokinetics C: Human
RS, Sbichter
in man. iron and M:
5, Adamson
Invest in Jacobs
JW,
43:17, A,
neous
Ricketts Iron Barosi kinetics, Medicine, Iron kinetics, counting. 17. Clin M (eds): M, p. 143 in Biochemistry G, Cazzola II. London, in Cramp
determination
Int J AppI Cook Invest JD, 49:197, of the
of Fe
Marsaglia 1970
and Fe
17:391, Eschbach
in blood
1966 JW,
by liquid
Funk iron DD,
scintillation
Finch CA: J
Worwood Academic,
1980, p 573
Ferrokinetics:
A biological
for plasma
exchange
in man.
3. Stefanebli
DG
Wiley,
(ed):
1982,
Quantitative
Approaches
to Metabolism.
New
York, JD
of J Clin
I 8. Huebers
Occupancy
HA, Josephson
iron binding
B, Huebers
sites of human
E, Csiba
transferrin.
E, Finch
Proc
CA:
NatI
4. Cook JD, Finch CA: Ferrokinetic measurements, in Cook (ed): Iron. New York, Churchill Livingstone, 1980, p 134
5. iron Pollycove kinetics and M, Mortimer hemoglobin R: The synthesis quantitative in human determination subjects.
81:4326, 1984 A, Aisen P: Distribution of iron between the binding in serum: Methods and results in normal human
53:1058, J, Moreton sites EJ, of 1979 K: The transferrin JV: distribution in human of iron serum. acquisition 27:739, 1980 T, Aisen P: Molecbetween Biochem of catathe J
Invest 40:753, 1961 6. Najean Y, Dresch C, Ardaillou N, Bernard J: Iron metabolism study of different models in normal conditions. Am J Physiol
213:533, 7. Basis I 982 8. Huebers HA, Csiba E, Huebers E, Finch CA: Competitive 1967 HA, iron Uvelli exchange D, Celada in the A, Josephson J Clin B, Finch Invest CA: 70:763, rabbit. Huebers of plasma
in the rat.
of absorbed
Huebers rat. turnover H, Finch Am
iron
E, Csiba
to transferrin.
E, Finch 1981 subjects. Effect 235:Rl8, CA:
Br J
The
advantage of diferric transferrin in delivering iron to reticulocytes. Proc NatI Acad Sci USA 80:300, 1983 9. Young SP, Bomford A, Williams R: The effect of the iron
saturation of transferrin on its binding and uptake by rabbit reticulo-
in the
Blood
57:218,
in normal CA:
J NucI
Med 22:107,
1970
of transferrin 1978 on iron in rats. J Physiol
cytes. Biochem J 219:505, 1984 10. Huebers HA, Csiba E, Huebers E, Finch CA: Molecular advantage of diferric transferrin in delivering iron to reticulocytes: A comparative study. Proc Exp Biol Med 179:222, 1985 I 1 . Bothwell TH, Charlton RW, Cook JD, Finch CA: Iron Metabolism in Man. Oxford, England, Blackwell Scientific, 1979
12.
in
Christensen
Nadler
SB,
Hidalgo
JV,
Bloch
T: Prediction
of blood
volume
normal human adults. Surgery 51:224, 1962 13. Najean Y, Cacchione R: Blood volume in health and disease. Clin Haematol 6:543, 1977 14. ICSH Expert Panel on Iron: Recommended methods for
measurementsofserum I 978 iron in human blood. BrJ Haematol 38:291,
Kariyone 5: Relationship among plasma iron, plasma iron turnover and reticuloendothelial iron release. Blood 61 :799, 1983
28. ferrin. 29. Morgan J Lab Cavill EH, Clin studies. Marsaglia Med 69:370, G, Giblett 1967 ER, Finch CA: A method
of investigating
internal I: The
iron exchange
utilizing
I 5. ICSH
Expert
Panel
on Iron:
The measurement
of total
and
ferrokinetic